Joseph R. Saveri

  • Biography
  • Key Cases
  • Accolades & Awards

Joseph R. Saveri specializes in antitrust law and complex civil and class action litigation in state, federal, and international arenas. With 30 years of civil litigation experience, he has handled cases involving numerous industries, including: banking and financial services, insurance, energy, pharmaceuticals, agricultural products, computer hardware, computer software, travel and transportation, paper products, cosmetics, and consumer electronics. Representing individuals, consumers, small business owners, public officials, and heads of corporations negatively affected by monopolistic business practices, he has established himself as one of the country’s top litigators in the antitrust field.

Joe has a long track record in the fields of antitrust law and complex litigation. In 1987, he started his career doing general litigation work at the San Francisco law firm of McCutchen, Doyle, Brown & Enersen. In 1992, he joined the plaintiffs’ firm Lieff, Cabraser, Heimann & Bernstein (LCHB), where he established and was the Managing Partner of the firm’s antitrust and intellectual property practice, which in 2012 was recognized as one of the top five practice groups in California.

During 20 years at LCHB, he handled numerous groundbreaking and landmark cases. This included litigation against Apple, Google, Intel, Adobe Systems, Pixar, Lucasfilm, and other tech companies for illegally agreeing not to poach each other’s employees; a class action representing direct purchasers in price-fixing claims against TFT-LCD manufacturers; a class action lawsuit on behalf of consumers and others against Bayer for exclusionary drug pricing agreements involving the generic version of the drug Cipro; and another landmark class action against De Beers SA, the diamond company, for monopolizing the rough diamond trade. He also served as lead counsel in other state and federal trials involving brand-name prescription drug price-fixing and the pharmaceutical industry.

Joe continues this high-profile work at the Joseph Saveri Law Firm, which he founded in May 2012 to provide the highest quality legal work to clients throughout the United States. Since the inception of the Firm, courts across the United States have appointed him and the Firm to leadership positions in important antitrust cases, class actions, and other complex litigation.

Joe is a frequent author of articles on antitrust and complex litigation issues, and a frequent lecturer on a variety of matters, including antitrust, complex litigation, class action practice, and discovery. He also serves as an author of California Antitrust and Unfair Competition Law, the legal treatise published by the State Bar of California’s Antitrust and Unfair Competition Section. He is on the Advisory Board of the American Antitrust Institute and is a Fellow of the Litigation Counsel of America. In 2019, he was a featured speaker at the U.S. Department of Justice Antitrust Division’s public roundtable to discuss the Antitrust Criminal Penalty Enhancement & Reform Act.  He also spoke at the University of Haifa’s (Israel) 3rd International Conference: Dispute Resolution of Consumer Mass Disputes, Collective Redress, Class Action, and ADR.

From 2010 through 2013, Joe served as a Lawyer Representative for the United States District Court for the Northern District of California and the Ninth Circuit Court of Appeals. He continues to serve on several court committees charged with developing rules and programs regarding complex litigation, e-discovery, and a variety of other matters. He was chosen to serve as a member of the Northern District’s Civil Rules Advisory Committee from 2009-2012, the committee to establish rules and procedures for expedited trials (which the Court adopted as General Order No. 64, “Expedited Trial Procedures”), and the committee which crafted new e-discovery rules and procedures recently adopted by the Court.

Joseph R. Saveri is a member of the American Bar Association (Antitrust Section), the Bar Association of San Francisco, and the Italian Lawyers Club of San Francisco.

  • Capacitors Price-Fixing Antitrust Litigation: The Firm is Sole Lead Counsel in a class action lawsuit alleging that global capacitor manufacturers conspired to fix prices, forcing direct purchasers to pay more. Class is certified and trial is ongoing in 2021. Initial settlements in the case total $439.55 million;
  • Cipro Antitrust Litigation: The Firm represents a class of California consumers and insurers who brought antitrust claims against Bayer Corporation, Barr Laboratories, and other generic drug manufacturers, alleging that the companies paid drug manufacturers to delay the release of a Cipro alternative. In May 2015, The California Supreme Court ruled in Plaintiffs’ favor. The case settled in 2017 for $399 million: a record for this type of case;
  • Dental Equipment Antitrust Litigation: The Firm represents dental equipment purchasers in a class action lawsuit alleging that three of the nation’s primary distributors of dental products illegally boycotted competitors in order to maintain and extend their dominant position in the market for dental supplies and equipment;
  • Generic Drug Price-Fixing Antitrust Litigation: The Firm is on the Plaintiffs’ Steering Committee representing U.S. consumers and insurers in a multi-district antitrust litigation accusing several generic drug manufacturers of conspiring to fix and raise prices for dozens of generic medications. In the past few years, prices for these drugs have skyrocketed by more than 1,000 percent. Consumers blame the companies for engineering these price hikes, eliminating the benefits of competition, and forcing them to pay exorbitant prices. The Firm is also currently investigating many other generic drugs for potential class action claims;
  • Global Distribution System (GDS) Technology Antitrust Litigation: The Firm serves as Co-Lead Counsel on behalf of U.S. air travel consumers. The lawsuit alleges that leading providers of GDS technology imposed unlawful contractual constraints on airlines that removed the airlines’ leverage to negotiate lower GDS fees and to develop alternative technologies. Two settlements have provided injunctive relief to the class;
  • High-Tech Employee Antitrust Litigation: The Firm served as Co-Lead Counsel and obtained in September 2015 a Court order approving a $415 million settlement against Google and other Defendants—the largest settlement ever obtained in an antitrust case brought on behalf of a class of employees;
  • HP Printer Firmware: The Firm has filed a class action lawsuit on behalf of U.S. consumers against HP Inc. The suit charges HP with designing and implementing a malicious firmware update to disable printers using competitors’ ink cartridges on affected computers to gain an advantage in the market;
  • Inductors Price-Fixing Cartel Litigation and Investigation: The Firm is litigating and investigating an alleged anticompetitive conspiracy involving manufacturers of inductors, a widely used passive electronic component. The investigation indicates, and the complaint alleges, that inductor manufacturers unlawfully agreed to fix the price of inductors shipped or invoiced to U.S. purchasers;
  • Lenovo Spyware Litigation: The Firm represents purchasers of certain models of Lenovo notebook computers in a class action lawsuit alleging that Lenovo installed and concealed spyware, resulting in multiple violations of federal computer fraud, racketeering, and consumer protection laws, as well as corollary and other common law claims under California, New York, and Ohio law;
  • LG/Samsung Antitrust Litigation: The Firm represents current and former LG and Samsung employees in a class action against the two electronics giants, alleging that they entered into an illegal no-poaching agreement that limits employee access to mobility and compensation;
  • Lidoderm Antitrust Litigation: The Firm serves as Liaison Counsel for Lidoderm End-Payors in a class action lawsuit against Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Inc., and Actavis Inc., along with their respective subsidiaries. The suit alleges that the companies entered into an illegal reverse pay agreement, forcing companies and consumers to pay higher prices for the Lidocaine-based pain patch, Lidoderm. The case settled in early 2018, shortly before trial, for $105 million;
  • Nomlaki Indians Litigation: The Firm is Co-Lead Counsel in a lawsuit filed on behalf of the Paskenta Band of Nomlaki Indians against former tribal officials, alleging that certain former tribal officials and others formed and operated a RICO enterprise to loot tens of millions of dollars in tribal moneys that were ultimately used for their own personal benefit;
  • Opana Antitrust Litigation: The Firm represents a Plaintiff in a proposed class action brought by California indirect purchasers against brand and generic manufacturers of Opana ER. Plaintiff alleges that Defendants Endo Pharmaceuticals Inc. and Impax Laboratories entered an illegal pay-for-delay or reverse payment agreement whereby Endo provided Impax over $100 million in cash, as well as other valuable consideration, in exchange for Impax’s promise to keep generic versions of Opana ER off the market. Plaintiff alleges this prevented generic competition and resulted in higher prices. In addition, Plaintiff alleges that Endo attempted an unlawful product hop to further raise prices to consumers;
  • Restasis Antitrust Litigation: The Firm represents the Self-Insured Schools of California in a class action lawsuit against Allergan, Inc. The suit alleges that Allergan participated in a scheme to delay generic competition to Allergan’s blockbuster Restasis drug and extended its monopoly in the Restasis market through a series of fraudulent and anticompetitive acts. On March 22, 2018, Judge Gershon appointed the Firm as Interim Co-Lead Counsel on behalf of End-Purchaser Plaintiffs;
  • UFC Antitrust Litigation: The Firm is Co-Lead Counsel for current and former Elite Professional Mixed Martial Arts (MMA) Fighters in an antitrust class action against Ultimate Fighting Championship (UFC), alleging that UFC illegally acquired and maintained a monopoly and monopsony power over Elite Professional MMA fighters, and used that power to suppress their compensation; and
  • Titanium Dioxide Antitrust Litigation: The Firm served as Co-Lead Counsel to a class of direct purchasers of titanium dioxide in an antitrust price-fixing case against titanium dioxide manufacturers DuPont, Huntsman, Millennium Inorganic Chemicals, and Kronos. This case produced a settlement of $165 million on the day before the trial was to commence.


  • 2021 Joseph Saveri
  • Martindale Hubbell 2019
  • 2018 TRL Badge
  • 2016 Clay
  • Saveri Super Lawyers 2019
  • 2018 Saveri SL Top 100
  • 2018 Saveri SL 10 years
  • Whos Who Legal
  • 2019 LD Plantiff Financial Lawyer
  • Best Lawyers 2021
  • legal-500
  • TOP PLAINTIFF 2021 BADGE Joseph Saveri